TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Gilead Sciences Sweden AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
483,388
|
351,162
|
330,835 |
Financial expenses |
0
|
337
|
969 |
Earnings before taxes |
23,107
|
12,291
|
10,610 |
EBITDA |
21,358
|
13,217
|
12,147 |
Total assets |
553,025
|
510,981
|
477,435 |
Current assets |
547,082
|
504,497
|
470,361 |
Current liabilities |
112,696
|
90,326
|
86,717 |
Equity capital |
180,786
|
163,844
|
154,637 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
58
|
54
|
50 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.7%
|
32.1%
|
32.4% |
Turnover per employee |
8,334
|
6,503
|
6,617 |
Profit as a percentage of turnover |
4.8%
|
3.5%
|
3.2% |
Return on assets (ROA) |
4.2%
|
2.5%
|
2.4% |
Current ratio |
485.4%
|
558.5%
|
542.4% |
Return on equity (ROE) |
12.8%
|
7.5%
|
6.9% |
Change turnover |
132,226
|
20,327
|
-32,399 |
Change turnover % |
38%
|
6%
|
-9% |
Chg. No. of employees |
4
![]() |
4
|
-3 |
Chg. No. of employees % |
7%
|
8%
|
-6% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.